Murray Stahl’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-109,308
Closed -$1.87M 325
2024
Q1
$1.87M Sell
109,308
-27,600
-20% -$434K 0.04% 109
2023
Q4
$2.42M Sell
136,908
-10,000
-7% -$201K 0.05% 86
2023
Q3
$3.53M Hold
146,908
0.07% 72
2023
Q2
$3.42M Buy
146,908
+1,000
+0.7% +$22.6K 0.07% 74
2023
Q1
$3.22M Buy
+145,908
New +$3.41M 0.06% 73

Other funds holding CLB

Murray Stahl's CLB Position: Q2 2024 in Review

Murray Stahl sold out of Core Laboratories (CLB) in Q2 2024, closing a stake of 109,308 shares — an estimated $1.87M sold.

Murray Stahl first reported a position in CLB in Q1 2023 and held it in 5 quarters. The position peaked at $3.53M in Q3 2023. 194 funds tracked by Wall St. Rank hold CLB as of Q2 2024.

  • Murray Stahl reported no remaining Core Laboratories position as of Q2 2024 after selling out during the quarter.
  • Murray Stahl sold 109,308 Core Laboratories shares in Q2 2024, an estimated $1.87M.
  • Murray Stahl first reported a position in Core Laboratories in Q1 2023 and held it in 5 quarters.
  • Murray Stahl's Core Laboratories position peaked at $3.53M in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2024.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.